Profile - Letrozole

Just a quick write up on a soon to be added compound to our brand

Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from Letrozole include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.
Femara®(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. Since many forms of breast cancer cells are stimulated by estrogen, it is hoped that by reducing amounts of estrogen in the body the progression of such a disease can be halted. This is the basic premise behind Nolvadex, except this drug blocks the action and not production of estrogen. The effects of Femara can be quite dramatic to say the least. A daily dose of one tablet (2.5 mg) can produce estrogen suppression greater than 80 % in treated patients. With the powerful effect this drug has on hormone levels, it is only to be used (clinically) by post-menopausal women whose disease has progressed following treatment with Nolvadex. Side effects like hot flushes and hair thinning can be present, and would no doubt be much more severe in pre-menopausal patients.

For the steroid using male athlete, Femara shows great potential. Up to this point, drugs like Nolvadex and Proviron have been our weapons against excess estrogen. These drugs, especially in combination, do prove quite effective. But Femara appears able to do the job much more efficiently, and with less hassle. Its use is only now catching on, but early reports have been excellent. A single tablet daily, the same dose use clinically, seems to be all one needs for an exceptional effect (some even report excellent results with only 1/4 tablet daily). When used with strong, readily aromatizing androgens such as Dianabol or testosterone, gynecomastia and water retention can be effectively blocked. In combination with Propecia (finasteride), we have a great advance. With the one drug halting estrogen conversion and the other blocking 5-alpha reduction (testosterone, methyltestosterone and Halotestin only), related side effects can be effectively minimized. Here the strong androgen testosterone could theoretically provide incredible muscular growth, while at the same time being as tolerable as nandrolone. Additionally the quality of the muscle should be greater, the athlete appearing harder and much more defined without holding excess water.
There are some concerns with using an aromatase inhibitor such as this during prolonged steroid treatment however. While it will effectively reduce estrogenic side effects, it will also block the beneficial properties of estrogen from becoming apparent (namely its effect on cholesterol values). Studies have clearly shown that when an aromatase inhibitor is used in conjunction with a steroid such as testosterone, suppression of HDL (good) cholesterol becomes much more pronounced. Apparently estrogen plays a role in minimizing the negative impact of steroid use. Since the estrogen receptor antagonist Nolvadex does not display an anti-estrogenic effect on cholesterol values, it is the preferred from of estrogen maintenance for those concerned with cardiovascular health.

Comments

Post a Comment

Popular posts from this blog

Steroid Profile - Masteron Propionate

Image
Time for a little profile on one of my favourite compounds, and not just because Genesis produce it, Ladies & Gentlemen I give to you Drostanolone Propionate - Or as we more commonly know it Masteron Propionate - http://genesis-ugl.com/index.php?id_product=20&controller=product Drostanolone Propionate is an anabolic androgenic steroid that first hit the market around 1970 under the trade name Masteron manufactured by Syntex. However, the compound was actually developed by Syntex in 1959 along with Oxymetholone (Anadrol) but would not be released until well after Anadrol. Syntex would also provide the compound under numerous other brand names such as Masteril and Metormon among others, as well as Drolban under the license given by Syntext to Lilly. However, Masteron has remained the most recognizable brand and the name by which we refer to the compound most regularly today. Masteron Functions & Traits: Drostanolone Propionate is a dihydrotesto
Read more

Product Breakdown - Genesis UK - Tri Tren - 250mg/ml

Product Breakdown - Genesis UK - Tri Tren - 250mg/ml Trenbolone Acetate - 100mg/ml Trenbolone Enanthate - 100mg/ml Trenbolone Hex - 50mg/ml Tri Tren / Tren Blend 10ml Multidose Vial Active Half Time 14 Days MG of Product 250mg Average Dosage 250mg-1000mg Weekly ML of Product 10ml --- Tri Tren TLDR Trenbolone greatly increases the level of the extremely anabolic hormone IGF-1 within muscle tissue. And, it’s worth noting that not only does it increase the levels of IGF-1 in muscle over two fold, it also causes muscle satellite cells (cells that repair damaged muscle) to be more sensitive to IGF-1 and other growth factors. The amount of DNA per muscle cell may also be significantly increased. Trenbolone also has a very strong binding affinity to the androgen receptor (A.R), binding much more strongly than testosterone. This is important, because the stronger a steroid binds to the androgen receptor the better that steroid works at activating A.R dependent mechani
Read more

Aromasin (exemestane)

Image
Exemestane is a steroidal Aromatase Inhibitor (AI) that is most commonly known as  Aromasin . In fact, the Aromasin brand name is the only pharmaceutical grade brand of the Exemestane AI due to the tight patent Upjohn has maintained on the product. While tightly controlled by the pharmaceutical giant, Aromasin is available in numerous countries around the globe. Aromasin was first released on the U.S. market in 2000 after shortly gaining FDA approval a few months prior in 1999. The primary purpose of use as with most AI’s would be to combat breast cancer in post-menopausal women. Shortly after, the AI would begin to gain a lot of popularity among anabolic steroid users for its ability to protect against estrogenic related side effects. This action is very similar to the older and more popular AI’s in Arimidex (Anastrozole) and Femara (Letrozole). It would also gain a fair amount of popularity in Post Cycle Therapy (PCT) plans among  steroid users . It was not the first AI to gai
Read more